+
Open data
-
Basic information
| Entry | Database: PDB / ID: 6ps7 | ||||||
|---|---|---|---|---|---|---|---|
| Title | XFEL A2aR structure by ligand exchange from LUF5843 to ZM241385. | ||||||
Components | Adenosine receptor A2a,Soluble cytochrome b562,Adenosine receptor A2a | ||||||
Keywords | MEMBRANE PROTEIN / GPCR / COMPLEX-LCP method / SBDD / drug design / XFEL / LCP-SFX / Ligand Exchange / Luf5843 / ZM241385 / A2aAR | ||||||
| Function / homology | Function and homology informationregulation of norepinephrine secretion / positive regulation of acetylcholine secretion, neurotransmission / negative regulation of alpha-beta T cell activation / positive regulation of circadian sleep/wake cycle, sleep / Adenosine P1 receptors / G protein-coupled adenosine receptor activity / response to purine-containing compound / G protein-coupled adenosine receptor signaling pathway / NGF-independant TRKA activation / Surfactant metabolism ...regulation of norepinephrine secretion / positive regulation of acetylcholine secretion, neurotransmission / negative regulation of alpha-beta T cell activation / positive regulation of circadian sleep/wake cycle, sleep / Adenosine P1 receptors / G protein-coupled adenosine receptor activity / response to purine-containing compound / G protein-coupled adenosine receptor signaling pathway / NGF-independant TRKA activation / Surfactant metabolism / sensory perception / positive regulation of urine volume / synaptic transmission, dopaminergic / type 5 metabotropic glutamate receptor binding / negative regulation of vascular permeability / synaptic transmission, cholinergic / positive regulation of glutamate secretion / intermediate filament / presynaptic active zone / blood circulation / response to caffeine / eating behavior / inhibitory postsynaptic potential / alpha-actinin binding / regulation of calcium ion transport / asymmetric synapse / axolemma / membrane depolarization / phagocytosis / cellular defense response / prepulse inhibition / positive regulation of synaptic transmission, glutamatergic / neuron projection morphogenesis / astrocyte activation / presynaptic modulation of chemical synaptic transmission / response to amphetamine / central nervous system development / positive regulation of long-term synaptic potentiation / positive regulation of apoptotic signaling pathway / positive regulation of synaptic transmission, GABAergic / regulation of mitochondrial membrane potential / positive regulation of protein secretion / excitatory postsynaptic potential / synaptic transmission, glutamatergic / locomotory behavior / apoptotic signaling pathway / electron transport chain / adenylate cyclase-modulating G protein-coupled receptor signaling pathway / negative regulation of inflammatory response / vasodilation / adenylate cyclase-activating G protein-coupled receptor signaling pathway / blood coagulation / cell-cell signaling / presynaptic membrane / G alpha (s) signalling events / phospholipase C-activating G protein-coupled receptor signaling pathway / negative regulation of neuron apoptotic process / postsynaptic membrane / periplasmic space / calmodulin binding / electron transfer activity / positive regulation of ERK1 and ERK2 cascade / iron ion binding / response to xenobiotic stimulus / inflammatory response / negative regulation of cell population proliferation / neuronal cell body / apoptotic process / heme binding / dendrite / lipid binding / regulation of DNA-templated transcription / protein-containing complex binding / glutamatergic synapse / enzyme binding / identical protein binding / membrane / plasma membrane Similarity search - Function | ||||||
| Biological species | Homo sapiens (human)![]() | ||||||
| Method | X-RAY DIFFRACTION / FREE ELECTRON LASER / MOLECULAR REPLACEMENT / molecular replacement / Resolution: 1.85 Å | ||||||
Authors | Ishchenko, A. / Stauch, B. / Han, G.W. / Batyuk, A. / Shiriaeva, A. / Li, C. / Zatsepin, N.A. / Weierstall, U. / Liu, W. / Nango, E. ...Ishchenko, A. / Stauch, B. / Han, G.W. / Batyuk, A. / Shiriaeva, A. / Li, C. / Zatsepin, N.A. / Weierstall, U. / Liu, W. / Nango, E. / Nakane, T. / Tanaka, R. / Tono, K. / Joti, Y. / Iwata, S. / Moraes, I. / Gati, C. / Cherezov, C. | ||||||
| Funding support | United States, 1items
| ||||||
Citation | Journal: Iucrj / Year: 2019Title: Toward G protein-coupled receptor structure-based drug design using X-ray lasers. Authors: Ishchenko, A. / Stauch, B. / Han, G.W. / Batyuk, A. / Shiriaeva, A. / Li, C. / Zatsepin, N. / Weierstall, U. / Liu, W. / Nango, E. / Nakane, T. / Tanaka, R. / Tono, K. / Joti, Y. / Iwata, S. ...Authors: Ishchenko, A. / Stauch, B. / Han, G.W. / Batyuk, A. / Shiriaeva, A. / Li, C. / Zatsepin, N. / Weierstall, U. / Liu, W. / Nango, E. / Nakane, T. / Tanaka, R. / Tono, K. / Joti, Y. / Iwata, S. / Moraes, I. / Gati, C. / Cherezov, V. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 6ps7.cif.gz | 190.5 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb6ps7.ent.gz | 147 KB | Display | PDB format |
| PDBx/mmJSON format | 6ps7.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 6ps7_validation.pdf.gz | 4.5 MB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 6ps7_full_validation.pdf.gz | 4.6 MB | Display | |
| Data in XML | 6ps7_validation.xml.gz | 19.7 KB | Display | |
| Data in CIF | 6ps7_validation.cif.gz | 27.3 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/ps/6ps7 ftp://data.pdbj.org/pub/pdb/validation_reports/ps/6ps7 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 6przC ![]() 6ps0C ![]() 6ps1C ![]() 6ps2C ![]() 6ps3C ![]() 6ps4C ![]() 6ps5C ![]() 6ps6C ![]() 6ps8C ![]() 4eiyS S: Starting model for refinement C: citing same article ( |
|---|---|
| Similar structure data |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||
| Unit cell |
| ||||||||
| Details | AUTHORS STATE THAT THE BIOLOGICAL UNIT IS UNKNOWN |
-
Components
-Protein , 1 types, 1 molecules A
| #1: Protein | Mass: 49386.484 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human), (gene. exp.) ![]() Gene: ADORA2A, ADORA2, cybC / Production host: ![]() |
|---|
-Non-polymers , 7 types, 133 molecules 












| #2: Chemical | ChemComp-ZMA / | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| #3: Chemical | ChemComp-OLC / ( #4: Chemical | #5: Chemical | ChemComp-OLB / ( | #6: Chemical | ChemComp-OLA / #7: Chemical | ChemComp-NA / | #8: Water | ChemComp-HOH / | |
-Details
| Has ligand of interest | Y |
|---|---|
| Has protein modification | Y |
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 2.62 Å3/Da / Density % sol: 53.13 % |
|---|---|
| Crystal grow | Temperature: 293 K / Method: lipidic cubic phase Details: 50mM sodium thiocyanate, 100 mM sodium citrate pH 4.8, and 28% PEG 400, 2 mM of target ligand ZM241385 |
-Data collection
| Diffraction | Mean temperature: 293 K / Serial crystal experiment: Y |
|---|---|
| Diffraction source | Source: FREE ELECTRON LASER / Site: SLAC LCLS / Beamline: CXI / Wavelength: 1.33 Å |
| Detector | Type: CS-PAD CXI-2 / Detector: PIXEL / Date: Dec 7, 2017 |
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 1.33 Å / Relative weight: 1 |
| Reflection | Resolution: 1.85→33.5 Å / Num. obs: 45163 / % possible obs: 100 % / Redundancy: 118 % / CC1/2: 0.983 / R split: 0.136 / Net I/σ(I): 4.6 |
| Reflection shell | Resolution: 1.85→1.9 Å / Num. unique obs: 3403 / CC1/2: 0.159 / R split: 2.17 |
| Serial crystallography measurement | Focal spot size: 1.5 µm2 / Pulse duration: 30 fsec. / Pulse photon energy: 9.83 keV / XFEL pulse repetition rate: 120 Hz |
| Serial crystallography sample delivery | Method: injection |
| Serial crystallography sample delivery injection | Flow rate: 0.2 µL/min / Injector diameter: 50 µm |
| Serial crystallography data reduction | Crystal hits: 68623 / Frames indexed: 39281 / Frames total: 241932 |
-Phasing
| Phasing | Method: molecular replacement |
|---|
-
Processing
| Software |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENTStarting model: 4eiy Resolution: 1.85→33.494 Å / SU ML: 0.27 / Cross valid method: THROUGHOUT / σ(F): 1.34 / Phase error: 20.52
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso max: 196.09 Å2 / Biso mean: 51.8642 Å2 / Biso min: 22.14 Å2 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: final / Resolution: 1.85→33.494 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell | Refine-ID: X-RAY DIFFRACTION / Rfactor Rfree error: 0 / % reflection obs: 100 %
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement TLS params. | Method: refined / Origin x: 17.114 Å / Origin y: 198.4344 Å / Origin z: 18.2995 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement TLS group | Selection details: chain 'A' |
Movie
Controller
About Yorodumi




Homo sapiens (human)
X-RAY DIFFRACTION
United States, 1items
Citation





















PDBj


















